M33.00 — Juvenile dermatomyositis, organ involvement unspecifiedICD-10-CM
No Prior Auth Required
No active coverage policies found for this code (low confidence)
L34771 — Immune Globulins
J05
A57554 — Billing and Coding: Immune Globulins
J05
A55639 — Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions
J05
L37205 — Chemotherapy Drugs and their Adjuncts
J05
L39624
Ask Verity about documentation requirements, denial risks, or coverage in your state.
J05
A59434 — Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J05
L39139 — Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J06
L35098 — Nerve Conduction Studies and Electromyography
J06
L40180 — Off-label Use of Rituximab and Rituximab Biosimilars
J06
A60186 — Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
J06
A57668 — Billing and Coding: Nerve Conduction Studies and Electromyography
J06
A60187 — Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG)
J06
L39297 — Off-label Use of Rituximab and Rituximab Biosimilars
J06
A59101 — Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
J06
A58893 — Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J06
A59105 — Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG)
J06
L39314 — Off-Label Use of Intravenous Immune Globulin (IVIG)
J06
L40181 — Off-Label Use of Intravenous Immune Globulin (IVIG)
J06
A56841 — Billing and Coding: Vitamin D; 25 hydroxy, includes fraction(s), if performed
J09
A59763 — Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J09